| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 798-800, Copyright © 1994 by Endocrine Society
ARTICLES |
A Chawla, EJ Schwarz, DD Dimaculangan and MA Lazar
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
Activators of peroxisome proliferator activated receptor (PPAR) regulate fatty acid metabolism and can induce adipocyte differentiation. We show here that the gamma subtype of PPAR is expressed at high levels in adipose tissue in contrast to a variety of other tissues, where little gene expression was noted. In addition, PPAR gamma is present at low levels in 3T3-L1 preadipocytes and is induced dramatically during adipocyte conversion using either normal differentiating conditions (fetal calf serum, dexamethasone, isobutyl- methylxanthine, and insulin) or the PPAR activator, WY-14,643. Thus PPAR gamma may be important for adipose cell development and function.
This article has been cited by other articles:
![]() |
T. Takazawa, T. Yamauchi, A. Tsuchida, M. Takata, Y. Hada, M. Iwabu, M. Okada-Iwabu, K. Ueki, and T. Kadowaki Peroxisome Proliferator-activated Receptor {gamma} Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes J. Biol. Chem., October 30, 2009; 284(44): 30049 - 30057. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. SERTZNIG, T. DUNLOP, M. SEIFERT, W. TILGEN, and J. REICHRATH Cross-talk between Vitamin D Receptor (VDR)- and Peroxisome Proliferator-activated Receptor (PPAR)-signaling in Melanoma Cells Anticancer Res, September 1, 2009; 29(9): 3647 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nofziger, K. K. Brown, C. D. Smith, W. Harrington, D. Murray, J. Bisi, T. T. Ashton, F. P. Maurio, K. Kalsi, T. A. West, et al. PPAR{gamma} agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line Am J Physiol Renal Physiol, July 1, 2009; 297(1): F55 - F62. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guilherme, G. J. Tesz, K. V. P. Guntur, and M. P. Czech Tumor Necrosis Factor-{alpha} Induces Caspase-mediated Cleavage of Peroxisome Proliferator-activated Receptor {gamma} in Adipocytes J. Biol. Chem., June 19, 2009; 284(25): 17082 - 17091. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schupp, A. G. Cristancho, M. I. Lefterova, E. A. Hanniman, E. R. Briggs, D. J. Steger, M. Qatanani, J. C. Curtin, J. Schug, S. A. Ochsner, et al. Re-expression of GATA2 Cooperates with Peroxisome Proliferator-activated Receptor-{gamma} Depletion to Revert the Adipocyte Phenotype J. Biol. Chem., April 3, 2009; 284(14): 9458 - 9464. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimada, N. Hiramatsu, K. Hayakawa, S. Takahashi, A. Kasai, Y. Tagawa, M. Mukai, J. Yao, Y. Fujii-Kuriyama, and M. Kitamura Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E721 - E730. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Helenius, Y. Yang, J. Alasaari, and T. P. Makela Mat1 Inhibits Peroxisome Proliferator-Activated Receptor {gamma}-Mediated Adipocyte Differentiation Mol. Cell. Biol., January 15, 2009; 29(2): 315 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Zizola, G. J. Schwartz, and S. Vogel Cellular retinol-binding protein type III is a PPAR{gamma} target gene and plays a role in lipid metabolism Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1358 - E1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Lefterova, Y. Zhang, D. J. Steger, M. Schupp, J. Schug, A. Cristancho, D. Feng, D. Zhuo, C. J. Stoeckert Jr., X. S. Liu, et al. PPAR{gamma} and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale Genes & Dev., November 1, 2008; 22(21): 2941 - 2952. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimada, N. Hiramatsu, A. Kasai, M. Mukai, M. Okamura, J. Yao, T. Huang, M. Tamai, S. Takahashi, T. Nakamura, et al. Suppression of adipocyte differentiation by Cordyceps militaris through activation of the aryl hydrocarbon receptor Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E859 - E867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Grant, G. Ortiz-Colon, M. E. Doumit, R. J. Tempelman, and D. D. Buskirk Differentiation of bovine intramuscular and subcutaneous stromal-vascular cells exposed to dexamethasone and troglitazone J Anim Sci, October 1, 2008; 86(10): 2531 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dallaire, K. Bellmann, M. Laplante, S. Gelinas, C. Centeno-Baez, P. Penfornis, M.-L. Peyot, M. G. Latour, J. Lamontagne, M. E. Trujillo, et al. Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator-Activated Receptor-{gamma} Agonism Diabetes, August 1, 2008; 57(8): 1999 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tuteja, S. T. Jensen, P. White, and K. H. Kaestner Cis-regulatory modules in the mammalian liver: composition depends on strength of Foxa2 consensus site Nucleic Acids Res., July 1, 2008; 36(12): 4149 - 4157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Rosen, B. D. Abbott, D. C. Wolf, J. C. Corton, C. R. Wood, J. E. Schmid, K. P. Das, R. D. Zehr, E. T. Blair, and C. Lau Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid Toxicol Pathol, June 1, 2008; 36(4): 592 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang and M. A. Lazar Bifunctional Role of Rev-erb{alpha} in Adipocyte Differentiation Mol. Cell. Biol., April 1, 2008; 28(7): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, M. Sato, Q. Li, J. P. Lydon, F. J. DeMayo, I. C. Bagchi, and M. K. Bagchi Peroxisome Proliferator-Activated Receptor {gamma} Is a Target of Progesterone Regulation in the Preovulatory Follicles and Controls Ovulation in Mice Mol. Cell. Biol., March 1, 2008; 28(5): 1770 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Miyawaki, S. Kamei, K. Sakayama, H. Yamamoto, and H. Masuno 4-Tert-Octylphenol Regulates the Differentiation of C3H10T1/2 Cells into Osteoblast and Adipocyte Lineages Toxicol. Sci., March 1, 2008; 102(1): 82 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Johnstone, P. S. Mongroo, A. S. Rich, M. Schupp, M. J. Bowser, A. S. deLemos, J. W. Tobias, Y. Liu, G. E. Hannigan, and A. K. Rustgi Parvin- Inhibits Breast Cancer Tumorigenicity and Promotes CDK9-Mediated Peroxisome Proliferator-Activated Receptor Gamma 1 Phosphorylation Mol. Cell. Biol., January 15, 2008; 28(2): 687 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Grant, G. Ortiz-Colon, M. E. Doumit, and D. D. Buskirk Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation J Anim Sci, January 1, 2008; 86(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Muhlhausler, J. A. Duffield, and I. C. McMillen Increased Maternal Nutrition Increases Leptin Expression in Perirenal and Subcutaneous Adipose Tissue in the Postnatal Lamb Endocrinology, December 1, 2007; 148(12): 6157 - 6163. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Anghel, E. Bedu, C. D. Vivier, P. Descombes, B. Desvergne, and W. Wahli Adipose Tissue Integrity as a Prerequisite for Systemic Energy Balance: A CRITICAL ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {gamma} J. Biol. Chem., October 12, 2007; 282(41): 29946 - 29957. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Mettu, T. B. Stanley, M. A. Dwyer, M. S. Jansen, J. E. Allen, J. M. Hall, and D. P. McDonnell The Nuclear Receptor-Coactivator Interaction Surface as a Target for Peptide Antagonists of the Peroxisome Proliferator-Activated Receptors Mol. Endocrinol., October 1, 2007; 21(10): 2361 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Han, S. Subramanian, C. K. Chan, M. Omer, T. Chiba, T. N. Wight, and A. Chait Adipocyte-Derived Serum Amyloid A3 and Hyaluronan Play a Role in Monocyte Recruitment and Adhesion Diabetes, September 1, 2007; 56(9): 2260 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, H. N. Zerby, and K. Lee Heart fatty acid binding protein is upregulated during porcine adipocyte development J Anim Sci, July 1, 2007; 85(7): 1651 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Qatanani and M. A. Lazar Mechanisms of obesity-associated insulin resistance: many choices on the menu Genes & Dev., June 15, 2007; 21(12): 1443 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schupp, J. C. Curtin, R. J. Kim, A. N. Billin, and M. A. Lazar A Widely Used Retinoic Acid Receptor Antagonist Induces Peroxisome Proliferator-Activated Receptor-{gamma} Activity Mol. Pharmacol., May 1, 2007; 71(5): 1251 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Brown and J. Plutzky Peroxisome Proliferator Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets Circulation, January 30, 2007; 115(4): 518 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, B. M. Necela, W. Su, M. Yanagisawa, P. Z. Anastasiadis, A. P. Fields, and E. A. Thompson Peroxisome Proliferator-activated Receptor {gamma} Promotes Epithelial to Mesenchymal Transformation by Rho GTPase-dependent Activation of ERK1/2 J. Biol. Chem., August 25, 2006; 281(34): 24575 - 24587. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lee, E. K. Yang, and S. G. Kim Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoic Acid X Receptor {alpha} Represses the TGFbeta1 Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 Dephosphorylation Mol. Pharmacol., July 1, 2006; 70(1): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Giordano, A. Y.M. Au, R. Kuick, D. G. Thomas, D. R. Rhodes, K. G. Wilhelm Jr., M. Vinco, D. E. Misek, D. Sanders, Z. Zhu, et al. Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation. Clin. Cancer Res., April 1, 2006; 12(7): 1983 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Wolins, B. K. Quaynor, J. R. Skinner, A. Tzekov, C. Park, K. Choi, and P. E. Bickel OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis J. Lipid Res., February 1, 2006; 47(2): 450 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blaschke, Y. Takata, E. Caglayan, R. E. Law, and W. A. Hsueh Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 28 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ando, H. Yanagihara, Y. Hayashi, Y. Obi, S. Tsuruoka, T. Takamura, S. Kaneko, and A. Fujimura Rhythmic Messenger Ribonucleic Acid Expression of Clock Genes and Adipocytokines in Mouse Visceral Adipose Tissue Endocrinology, December 1, 2005; 146(12): 5631 - 5636. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brachvogel, H. Moch, F. Pausch, U. Schlotzer-Schrehardt, C. Hofmann, R. Hallmann, K. von der Mark, T. Winkler, and E. Poschl Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages Development, June 1, 2005; 132(11): 2657 - 2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Guan, T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar Corepressors selectively control the transcriptional activity of PPAR{gamma} in adipocytes Genes & Dev., February 15, 2005; 19(4): 453 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Knouff and J. Auwerx Peroxisome Proliferator-Activated Receptor-{gamma} Calls for Activation in Moderation: Lessons from Genetics and Pharmacology Endocr. Rev., December 1, 2004; 25(6): 899 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. Camacho, L. Serneels, K. Spittaels, P. Merchiers, D. Dominguez, and B. De Strooper Peroxisome Proliferator-Activated Receptor {gamma} Induces a Clearance Mechanism for the Amyloid-{beta} Peptide J. Neurosci., December 1, 2004; 24(48): 10908 - 10917. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Subbarayan, A. L. Sabichi, J. Kim, N. Llansa, C. J. Logothetis, S. M. Lippman, and D. G. Menter Differential Peroxisome Proliferator-Activated Receptor-{gamma} Isoform Expression and Agonist Effects in Normal and Malignant Prostate Cells Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1710 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matsui, Y. Terauchi, N. Kubota, I. Takamoto, K. Eto, T. Yamashita, K. Komeda, T. Yamauchi, J. Kamon, S. Kita, et al. Pioglitazone Reduces Islet Triglyceride Content and Restores Impaired Glucose-Stimulated Insulin Secretion in Heterozygous Peroxisome Proliferator-Activated Receptor-{gamma}-Deficient Mice on a High-Fat Diet Diabetes, November 1, 2004; 53(11): 2844 - 2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Coughlan, M. Permezel, H. M. Georgiou, and G. E. Rice Repression of Oxidant-Induced Nuclear Factor-{kappa}B Activity Mediates Placental Cytokine Responses in Gestational Diabetes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3585 - 3594. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Park, I. J. Cho, and S. G. Kim Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer Cancer Res., May 15, 2004; 64(10): 3701 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zayzafoon, W. E. Gathings, and J. M. McDonald Modeled Microgravity Inhibits Osteogenic Differentiation of Human Mesenchymal Stem Cells and Increases Adipogenesis Endocrinology, May 1, 2004; 145(5): 2421 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sekiya, J.-i. Osuga, H. Okazaki, N. Yahagi, K. Harada, W.-J. Shen, Y. Tamura, S. Tomita, Y. Iizuka, K. Ohashi, et al. Absence of Hormone-sensitive Lipase Inhibits Obesity and Adipogenesis in Lepob/ob Mice J. Biol. Chem., April 9, 2004; 279(15): 15084 - 15090. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Hsueh and D. Bruemmer Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease Hypertension, February 1, 2004; 43(2): 297 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asada, S. Sasaki, T. Suda, K. Chida, and H. Nakamura Antiinflammatory Roles of Peroxisome Proliferator-activated Receptor {gamma} in Human Alveolar Macrophages Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bildirici, C.-R. Roh, W. T. Schaiff, B. M. Lewkowski, D. M. Nelson, and Y. Sadovsky The Lipid Droplet-Associated Protein Adipophilin Is Expressed in Human Trophoblasts and Is Regulated by Peroxisomal Proliferator-Activated Receptor-{gamma}/Retinoid X Receptor J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6056 - 6062. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dowell, T. C. Otto, S. Adi, and M. D. Lane Convergence of Peroxisome Proliferator-activated Receptor {gamma} and Foxo1 Signaling Pathways J. Biol. Chem., November 14, 2003; 278(46): 45485 - 45491. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Koumas, T. J. Smith, S. Feldon, N. Blumberg, and R. P. Phipps Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes Am. J. Pathol., October 1, 2003; 163(4): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gavrilova, M. Haluzik, K. Matsusue, J. J. Cutson, L. Johnson, K. R. Dietz, C. J. Nicol, C. Vinson, F. J. Gonzalez, and M. L. Reitman Liver Peroxisome Proliferator-activated Receptor {gamma} Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass J. Biol. Chem., September 5, 2003; 278(36): 34268 - 34276. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aoun, J. W. Simpkins, and N. Agarwal Role of PPAR-{gamma} Ligands In Neuroprotection against Glutamate-Induced Cytotoxicity in Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2999 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Giusti, C. Verdumo, M. Suter, R. C. Gaillard, P. Burckhardt, and F. Pralong Expression of Peroxisome Proliferator-Activated Receptor-{gamma}1 and Peroxisome Proliferator-Activated Receptor-{gamma}2 in Visceral and Subcutaneous Adipose Tissue of Obese Women Diabetes, July 1, 2003; 52(7): 1673 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ameshima, H. Golpon, C. D. Cool, D. Chan, R. W. Vandivier, S. J. Gardai, M. Wick, R. A. Nemenoff, M. W. Geraci, and N. F. Voelkel Peroxisome Proliferator-Activated Receptor Gamma (PPAR{gamma}) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth Circ. Res., May 30, 2003; 92(10): 1162 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dello Russo, V. Gavrilyuk, G. Weinberg, A. Almeida, J. P. Bolanos, J. Palmer, D. Pelligrino, E. Galea, and D. L. Feinstein Peroxisome Proliferator-activated Receptor gamma Thiazolidinedione Agonists Increase Glucose Metabolism in Astrocytes J. Biol. Chem., February 14, 2003; 278(8): 5828 - 5836. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Seda, L. Kazdova, D. Krenova, and V. Kren Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain Physiol Genomics, January 15, 2003; 12(2): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kajita, T. Ishizuka, T. Mune, A. Miura, M. Ishizawa, Y. Kanoh, Y. Kawai, Y. Natsume, and K. Yasuda Dehydroepiandrosterone Down-Regulates the Expression of Peroxisome Proliferator-Activated Receptor {gamma} in Adipocytes Endocrinology, January 1, 2003; 144(1): 253 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yeh, M.-Y. Tsai, Q. Xu, X.-M. Mu, H. Lardy, K.-E. Huang, H. Lin, S.-D. Yeh, S. Altuwaijri, X. Zhou, et al. Generation and characterization of androgen receptor knockout (ARKO) mice: An in vivo model for the study of androgen functions in selective tissues PNAS, October 15, 2002; 99(21): 13498 - 13503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marso Optimizing the diabetic formulary: beyond aspirin and insulin J. Am. Coll. Cardiol., August 21, 2002; 40(4): 652 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Childs, D. W. Goad, M. F. Allan, D. Pomp, C. Krehbiel, R. D. Geisert, J. B. Morgan, and J. R. Malayer Differential expression of NAT1 translational repressor during development of bovine intramuscular adipocytes Physiol Genomics, August 14, 2002; 10(2): 49 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-S. Tan, N. S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, B. Desvergne, W. Wahli, and N. Noy Selective Cooperation between Fatty Acid Binding Proteins and Peroxisome Proliferator-Activated Receptors in Regulating Transcription Mol. Cell. Biol., July 15, 2002; 22(14): 5114 - 5127. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cui, K. Miyoshi, E. Claudio, U. K. Siebenlist, F. J. Gonzalez, J. Flaws, K.-U. Wagner, and L. Hennighausen Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARgamma ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced Fertility J. Biol. Chem., May 10, 2002; 277(20): 17830 - 17835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li and M. A. Lazar Differential Gene Regulation by PPAR{gamma} Agonist and Constitutively Active PPAR{gamma}2 Mol. Endocrinol., May 1, 2002; 16(5): 1040 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Schild, W. T. Schaiff, M. G. Carlson, E. J. Cronbach, D. M. Nelson, and Y. Sadovsky The Activity of PPAR{gamma} in Primary Human Trophoblasts Is Enhanced by Oxidized Lipids J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1105 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Clark The role of PPARs in inflammation and immunity J. Leukoc. Biol., March 1, 2002; 71(3): 388 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rangwala and M. A. Lazar The Dawn of the SPPARMs? Sci. Signal., February 26, 2002; 2002(121): pe9 - pe9. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oyama, N. Akuzawa, R. Nagai, and M. Kurabayashi PPAR{gamma} Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 Cells Circ. Res., February 22, 2002; 90(3): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. E. Floyd and J. M. Stephens Interferon-gamma -mediated Activation and Ubiquitin-Proteasome-dependent Degradation of PPARgamma in Adipocytes J. Biol. Chem., February 1, 2002; 277(6): 4062 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lazar Becoming fat Genes & Dev., January 1, 2002; 16(1): 1 - 5. [Full Text] [PDF] |
||||
![]() |
R. M. David, M. R. Moore, D. C. Finney, and D. Guest Reversibility of the Chronic Effects of Di(2-ethylhexyl)phthalate Toxicol Pathol, June 1, 2001; 29(4): 430 - 439. [Abstract] [PDF] |
||||
![]() |
M. Caron, M. Auclair, C. Vigouroux, M. Glorian, C. Forest, and J. Capeau The HIV Protease Inhibitor Indinavir Impairs Sterol Regulatory Element-Binding Protein-1 Intranuclear Localization, Inhibits Preadipocyte Differentiation, and Induces Insulin Resistance Diabetes, June 1, 2001; 50(6): 1378 - 1388. [Abstract] [Full Text] |
||||
![]() |
K. Ohta, T. Endo, K. Haraguchi, J. M. Hershman, and T. Onaya Ligands for Peroxisome Proliferator-Activated Receptor {{gamma}} Inhibit Growth and Induce Apoptosis of Human Papillary Thyroid Carcinoma Cells J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2170 - 2177. [Abstract] [Full Text] |
||||
![]() |
E. C. Person, L. L. Waite, R. N. Taylor, and T. S. Scanlan Albumin Regulates Induction of Peroxisome Proliferator-Activated Receptor-{{gamma}} (PPAR{{gamma}}) by 15-Deoxy-{{Delta}}12-14-Prostaglandin J2 in Vitro and May Be an Important Regulator of PPAR{{gamma}} Function in Vivo Endocrinology, February 1, 2001; 142(2): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Steppan, E. J. Brown, C. M. Wright, S. Bhat, R. R. Banerjee, C. Y. Dai, G. H. Enders, D. G. Silberg, X. Wen, G. D. Wu, et al. A family of tissue-specific resistin-like molecules PNAS, January 16, 2001; 98(2): 502 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Schaiff, M. G. Carlson, S. D. Smith, R. Levy, D. M. Nelson, and Y. Sadovsky Peroxisome Proliferator-Activated Receptor-{gamma} Modulates Differentiation of Human Trophoblast in a Ligand-Specific Manner J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3874 - 3881. [Abstract] [Full Text] |
||||
![]() |
J.-i. Hisatake, T. Ikezoe, M. Carey, S. Holden, S. Tomoyasu, and H. P. Koeffler Down-Regulation of Prostate-specific Antigen Expression by Ligands for Peroxisome Proliferator-activated Receptor {{gamma}} in Human Prostate Cancer Cancer Res., October 1, 2000; 60(19): 5494 - 5498. [Abstract] [Full Text] |
||||
![]() |
C. Huin, L. Corriveau, A. Bianchi, J. M. Keller, P. Collet, P. Krémarik-Bouillaud, L. Domenjoud, P. Bécuwe, H. Schohn, D. Ménard, et al. Differential Expression of Peroxisome Proliferator-activated Receptors (PPARs) in the Developing Human Fetal Digestive Tract J. Histochem. Cytochem., May 1, 2000; 48(5): 603 - 612. [Abstract] [Full Text] |
||||
![]() |
R. G. Mehta, E. Williamson, M. K. Patel, and H. P. Koeffler A Ligand of Peroxisome Proliferator-Activated Receptor {gamma}, Retinoids, and Prevention of Preneoplastic Mammary Lesions J Natl Cancer Inst, March 1, 2000; 92(5): 418 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S. J. Padula The Nuclear Receptor PPAR{gamma} and Immunoregulation: PPAR{gamma} Mediates Inhibition of Helper T Cell Responses J. Immunol., February 1, 2000; 164(3): 1364 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Sartippour and G. Renier Differential Regulation of Macrophage Peroxisome Proliferator-Activated Receptor Expression by Glucose : Role of Peroxisome Proliferator-Activated Receptors in Lipoprotein Lipase Gene Expression Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 104 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Desvergne and W. Wahli Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism Endocr. Rev., October 1, 1999; 20(5): 649 - 688. [Abstract] [Full Text] |
||||
![]() |
C. E. Clay, A. M. Namen, G.-i. Atsumi, M. C. Willingham, K. P. High, T. E. Kute, A. J. Trimboli, A. N. Fonteh, P. A. Dawson, and F. H. Chilton Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells Carcinogenesis, October 1, 1999; 20(10): 1905 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bastie, D. Holst, D. Gaillard, C. Jehl-Pietri, and P. A. Grimaldi Expression of Peroxisome Proliferator-activated Receptor PPARdelta Promotes Induction of PPARgamma and Adipocyte Differentiation in 3T3C2 Fibroblasts J. Biol. Chem., July 30, 1999; 274(31): 21920 - 21925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Febbraio, N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. A. Pearce, and R. L. Silverstein A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism J. Biol. Chem., July 2, 1999; 274(27): 19055 - 19062. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Heinlein, H.-J. Ting, S. Yeh, and C. Chang Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor gamma J. Biol. Chem., June 4, 1999; 274(23): 16147 - 16152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kliewer, J. M. Lehmann, and T. M. Willson Orphan Nuclear Receptors: Shifting Endocrinology into Reverse Science, April 30, 1999; 284(5415): 757 - 760. [Abstract] [Full Text] |
||||
![]() |
C. E. Robinson, X. Wu, Z. Nawaz, S. A. Onãte, and J. M. Gimble A Corepressor and Chicken Ovalbumin Upstream Promoter Transcriptional Factor Proteins Modulate Peroxisome Proliferator-Activated Receptor-{gamma}2/Retinoid X Receptor {alpha}-Activated Transcription from the Murine Lipoprotein Lipase Promoter Endocrinology, April 1, 1999; 140(4): 1586 - 1593. [Abstract] [Full Text] |
||||
![]() |
Y.-T. Zhou, Z.-W. Wang, M. Higa, C. B. Newgard, and R. H. Unger Reversing adipocyte differentiation: Implications for treatment of obesity PNAS, March 2, 1999; 96(5): 2391 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Frohnert, T. Y. Hui, and D. A. Bernlohr Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene J. Biol. Chem., February 12, 1999; 274(7): 3970 - 3977. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Hansen, R. K. Petersen, B. M. Larsen, J. Bartkova, J. Alsner, and K. Kristiansen Activation of Peroxisome Proliferator-activated Receptor gamma Bypasses the Function of the Retinoblastoma Protein in Adipocyte Differentiation J. Biol. Chem., January 22, 1999; 274(4): 2386 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Gros, C. Gerhardt, and A. Strosberg Expression of human (beta)3-adrenergic receptor induces adipocyte-like features in CHO/K1 fibroblasts J. Cell Sci., January 11, 1999; 112(21): 3791 - 3797. [Abstract] [PDF] |
||||
![]() |
H. S. Camp, S. R. Tafuri, and T. Leff c-Jun N-Terminal Kinase Phosphorylates Peroxisome Proliferator-Activated Receptor-{gamma}1 and Negatively Regulates Its Transcriptional Activity Endocrinology, January 1, 1999; 140(1): 392 - 397. [Abstract] [Full Text] |
||||
![]() |
V. Ribon, J. H. Johnson, H. S. Camp, and A. R. Saltiel Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene PNAS, December 8, 1998; 95(25): 14751 - 14756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Reginato, S. T. Bailey, S. L. Krakow, C. Minami, S. Ishii, H. Tanaka, and M. A. Lazar A Potent Antidiabetic Thiazolidinedione with Unique Peroxisome Proliferator-activated Receptor gamma -activating Properties J. Biol. Chem., December 4, 1998; 273(49): 32679 - 32684. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ma, H. W. Sprecher, and P. E. Kolattukudy Estrogen-induced Production of a Peroxisome Proliferator-activated Receptor (PPAR) Ligand in a PPARgamma -expressing Tissue J. Biol. Chem., November 13, 1998; 273(46): 30131 - 30138. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Blumberg and R. M. Evans Orphan nuclear receptors---new ligands and new possibilities Genes & Dev., October 15, 1998; 12(20): 3149 - 3155. [Full Text] |
||||
![]() |
R. A. Baillie, X. Sha, P. Thuillier, and S. D. Clarke A novel 3T3-L1 preadipocyte variant that expresses PPAR{gamma}2 and RXR{alpha} but does not undergo differentiation J. Lipid Res., October 1, 1998; 39(10): 2048 - 2053. [Abstract] [Full Text] |
||||
![]() |
L. H. Hansen, B. Madsen, B. Teisner, J. H. Nielsen, and N. Billestrup Characterization of the Inhibitory Effect of Growth Hormone on Primary Preadipocyte Differentiation Mol. Endocrinol., August 1, 1998; 12(8): 1140 - 1149. [Abstract] [Full Text] |
||||
![]() |
E. Elstner, C. Muller, K. Koshizuka, E. A. Williamson, D. Park, H. Asou, P. Shintaku, J. W. Said, D. Heber, and H. P. Koeffler Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice PNAS, July 21, 1998; 95(15): 8806 - 8811. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ricote, J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J. L. Witztum, J. Auwerx, W. Palinski, and C. K. Glass Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein PNAS, June 23, 1998; 95(13): 7614 - 7619. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |